SUPN - Supernus to Participate in Two Upcoming Investor Conferences | Benzinga
ROCKVILLE, Md., March 06, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate in the following March investor conferences:
| Jefferies Biotech on the Bay Summit |
| Date: |
| Tuesday, March 12, 2024 |
| Place: |
| The 1 Hotel South Beach, Miami, Fla. |
| Barclays Global Healthcare Conference |
| Date: |
| Wednesday, March 13, 2024 |
| Fireside chat: |
| 3:35 p.m. ET |
| Place: |
| Loews Miami Beach Hotel, Miami, Fla. |
Investors interested in arranging a meeting with the Company's management during these conferences should contact the respective conference coordinators. A live audio webcast of the Company's fireside chat at the Barclays Global Healthcare Conference can be accessed here or by visiting the Events & Presentations section of the Company's Investor Relations website at www.supernus.com/investors. An archived replay of the webcast will be available for 60 days on the Company's website following the conference.
About Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases.
Our diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, ADHD, hypomobility in Parkinson's disease (PD), cervical dystonia, chronic sialorrhea, ...